aluates Reports

$ 0.0

Automative

Global Sterile Formulation Development Market Research Report 2026

Published Date: 2026-01-23

Report Code: QYRE-Auto-19Q16890

Sterile Formulation Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

BUY CHAPTERS

Global Sterile Formulation Development Market Research Report 2026

Code: QYRE-Auto-19Q16890

Report

2026-01-23

Pages:134

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific

Pfizer CentreOne

Piramal Pharma Solutions

Ardena

Curida

Curia Global

Carbogen-Amcis

Cambrex

Aenova Group

Catalent

Althea

Baxter

Sterile Formulation Development Market Size

The global Sterile Formulation Development market was valued at US$ 6153 million in 2025 and is anticipated to reach US$ 10035 million by 2032, at a CAGR of 7.2% from 2026 to 2032.

Sterile Formulation Development Market

Sterile Formulation Development (SFR) refers to the entire research and development process conducted in a sterile environment that meets GMP (Good Manufacturing Practice) requirements. This process encompasses formulation design, process optimization, sterility validation, stability studies, and industrialization for drug dosage forms such as injections, ophthalmic preparations, and inhaled preparations, which require strict control of microbial contamination. Its core objective is to ensure that the formulation is free of live bacteria, pyrogens, and visible foreign matter throughout its entire lifecycle—from production and storage to use—by screening suitable active pharmaceutical ingredients (APIs), excipients, and manufacturing processes. Simultaneously, it guarantees the drug's efficacy, safety, and stability, meeting the quality requirements of clinical practice for high-risk drug dosage forms. SFRs are widely used in antibiotics, biologics, antitumor drugs, and emergency medications.

With the rapid development of biopharmaceuticals such as monoclonal antibodies, bispecific antibodies, recombinant proteins, and vaccines, the demand for sterile formulations targeting biological macromolecules has surged. Research and development focuses on screening lyophilization protectants, protein stabilization technologies, and single-use manufacturing processes to address the challenges of biopharmaceutical degradation and aggregation. Simultaneously, novel sterile dosage forms adapted to biopharmaceuticals (such as long-acting sustained-release injections and subcutaneous microspheres) have become a research hotspot, improving the convenience of clinical administration and the duration of therapeutic efficacy.

Market demand is expanding from conventional injections to complex sterile formulations such as liposomes, microspheres, nanoparticles, and in-situ gels. These formulations enable targeted drug delivery and controlled-release, increasing drug concentration at the lesion site. Furthermore, the development of sterile formulations for special administration routes, such as ophthalmic sterile gels, sterile inhaled powders, and sterile nasal sprays, is accelerating to meet the clinical needs of specialties such as ophthalmology and respiratory medicine.

This report delivers a comprehensive overview of the global Sterile Formulation Development market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sterile Formulation Development. The Sterile Formulation Development market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sterile Formulation Development market comprehensively. Regional market sizes by Type, by Application, by Dosage Form, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sterile Formulation Development manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Sterile Formulation Development Market Report

Report Metric	Details
Report Name	Sterile Formulation Development Market
Accounted market size in 2025	US$ 6153 million
Forecasted market size in 2032	US$ 10035 million
CAGR	7.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Liquid Dosage Form Lyophilized Dosage Form Frozen Dosage Form Others
Segment by Dosage Form	Injection Ophthalmic Inhalation Others
Segment by Drug	Chemical Drugs Biopharmaceuticals Traditional Chinese Medicine Others
Segment by Application	Preclinical Clinical Commercial
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Catalent, Lonza Group AG, Recipharm AB, Samsung Biologics, Aenova Group, Thermo Fisher Scientific, Pfizer CentreOne, Piramal Pharma Solutions, Ardena, Curida, Curia Global, Carbogen Amcis, Oakwood Labs, Cambrex, Almac Group, Asymchem Group, AGC Biologics, WuXi AppTec, Althea, Baxter
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Dosage Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Sterile Formulation Development companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Sterile Formulation Development Market growing?

Ans: The Sterile Formulation Development Market witnessing a CAGR of 7.2% during the forecast period 2026-2032.

What is the Sterile Formulation Development Market size in 2032?

Ans: The Sterile Formulation Development Market size in 2032 will be US$ 10035 million.

Who are the main players in the Sterile Formulation Development Market report?

Ans: The main players in the Sterile Formulation Development Market are Catalent, Lonza Group AG, Recipharm AB, Samsung Biologics, Aenova Group, Thermo Fisher Scientific, Pfizer CentreOne, Piramal Pharma Solutions, Ardena, Curida, Curia Global, Carbogen Amcis, Oakwood Labs, Cambrex, Almac Group, Asymchem Group, AGC Biologics, WuXi AppTec, Althea, Baxter

What are the Application segmentation covered in the Sterile Formulation Development Market report?

Ans: The Applications covered in the Sterile Formulation Development Market report are Preclinical, Clinical, Commercial

What are the Type segmentation covered in the Sterile Formulation Development Market report?

Ans: The Types covered in the Sterile Formulation Development Market report are Liquid Dosage Form, Lyophilized Dosage Form, Frozen Dosage Form, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sterile Formulation Development Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Liquid Dosage Form

1.2.3 Lyophilized Dosage Form

1.2.4 Frozen Dosage Form

1.2.5 Others

1.3 Market by Dosage Form

1.3.1 Global Sterile Formulation Development Market Size Growth Rate by Dosage Form: 2021 vs 2025 vs 2032

1.3.2 Injection

1.3.3 Ophthalmic

1.3.4 Inhalation

1.3.5 Others

1.4 Market by Drug

1.4.1 Global Sterile Formulation Development Market Size Growth Rate by Drug: 2021 vs 2025 vs 2032

1.4.2 Chemical Drugs

1.4.3 Biopharmaceuticals

1.4.4 Traditional Chinese Medicine

1.4.5 Others

1.5 Market by Application

1.5.1 Global Sterile Formulation Development Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Preclinical

1.5.3 Clinical

1.5.4 Commercial

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Sterile Formulation Development Market Perspective (2021–2032)

2.2 Global Sterile Formulation Development Growth Trends by Region

2.2.1 Global Sterile Formulation Development Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Sterile Formulation Development Historic Market Size by Region (2021–2026)

2.2.3 Sterile Formulation Development Forecasted Market Size by Region (2027–2032)

2.3 Sterile Formulation Development Market Dynamics

2.3.1 Sterile Formulation Development Industry Trends

2.3.2 Sterile Formulation Development Market Drivers

2.3.3 Sterile Formulation Development Market Challenges

2.3.4 Sterile Formulation Development Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sterile Formulation Development Players by Revenue

3.1.1 Global Top Sterile Formulation Development Players by Revenue (2021–2026)

3.1.2 Global Sterile Formulation Development Revenue Market Share by Players (2021–2026)

3.2 Global Top Sterile Formulation Development Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Sterile Formulation Development Revenue

3.4 Global Sterile Formulation Development Market Concentration Ratio

3.4.1 Global Sterile Formulation Development Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sterile Formulation Development Revenue in 2025

3.5 Global Key Players of Sterile Formulation Development Head Offices and Areas Served

3.6 Global Key Players of Sterile Formulation Development, Products and Applications

3.7 Global Key Players of Sterile Formulation Development, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Sterile Formulation Development Breakdown Data by Type

4.1 Global Sterile Formulation Development Historic Market Size by Type (2021–2026)

4.2 Global Sterile Formulation Development Forecasted Market Size by Type (2027–2032)

5 Sterile Formulation Development Breakdown Data by Application

5.1 Global Sterile Formulation Development Historic Market Size by Application (2021–2026)

5.2 Global Sterile Formulation Development Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Sterile Formulation Development Market Size (2021–2032)

6.2 North America Sterile Formulation Development Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Sterile Formulation Development Market Size by Country (2021–2026)

6.4 North America Sterile Formulation Development Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sterile Formulation Development Market Size (2021–2032)

7.2 Europe Sterile Formulation Development Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Sterile Formulation Development Market Size by Country (2021–2026)

7.4 Europe Sterile Formulation Development Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Sterile Formulation Development Market Size (2021–2032)

8.2 Asia-Pacific Sterile Formulation Development Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Sterile Formulation Development Market Size by Region (2021–2026)

8.4 Asia-Pacific Sterile Formulation Development Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Sterile Formulation Development Market Size (2021–2032)

9.2 Latin America Sterile Formulation Development Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Sterile Formulation Development Market Size by Country (2021–2026)

9.4 Latin America Sterile Formulation Development Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sterile Formulation Development Market Size (2021–2032)

10.2 Middle East & Africa Sterile Formulation Development Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Sterile Formulation Development Market Size by Country (2021–2026)

10.4 Middle East & Africa Sterile Formulation Development Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Catalent

11.1.1 Catalent Company Details

11.1.2 Catalent Business Overview

11.1.3 Catalent Sterile Formulation Development Introduction

11.1.4 Catalent Revenue in Sterile Formulation Development Business (2021–2026)

11.1.5 Catalent Recent Development

11.2 Lonza Group AG

11.2.1 Lonza Group AG Company Details

11.2.2 Lonza Group AG Business Overview

11.2.3 Lonza Group AG Sterile Formulation Development Introduction

11.2.4 Lonza Group AG Revenue in Sterile Formulation Development Business (2021–2026)

11.2.5 Lonza Group AG Recent Development

11.3 Recipharm AB

11.3.1 Recipharm AB Company Details

11.3.2 Recipharm AB Business Overview

11.3.3 Recipharm AB Sterile Formulation Development Introduction

11.3.4 Recipharm AB Revenue in Sterile Formulation Development Business (2021–2026)

11.3.5 Recipharm AB Recent Development

11.4 Samsung Biologics

11.4.1 Samsung Biologics Company Details

11.4.2 Samsung Biologics Business Overview

11.4.3 Samsung Biologics Sterile Formulation Development Introduction

11.4.4 Samsung Biologics Revenue in Sterile Formulation Development Business (2021–2026)

11.4.5 Samsung Biologics Recent Development

11.5 Aenova Group

11.5.1 Aenova Group Company Details

11.5.2 Aenova Group Business Overview

11.5.3 Aenova Group Sterile Formulation Development Introduction

11.5.4 Aenova Group Revenue in Sterile Formulation Development Business (2021–2026)

11.5.5 Aenova Group Recent Development

11.6 Thermo Fisher Scientific

11.6.1 Thermo Fisher Scientific Company Details

11.6.2 Thermo Fisher Scientific Business Overview

11.6.3 Thermo Fisher Scientific Sterile Formulation Development Introduction

11.6.4 Thermo Fisher Scientific Revenue in Sterile Formulation Development Business (2021–2026)

11.6.5 Thermo Fisher Scientific Recent Development

11.7 Pfizer CentreOne

11.7.1 Pfizer CentreOne Company Details

11.7.2 Pfizer CentreOne Business Overview

11.7.3 Pfizer CentreOne Sterile Formulation Development Introduction

11.7.4 Pfizer CentreOne Revenue in Sterile Formulation Development Business (2021–2026)

11.7.5 Pfizer CentreOne Recent Development

11.8 Piramal Pharma Solutions

11.8.1 Piramal Pharma Solutions Company Details

11.8.2 Piramal Pharma Solutions Business Overview

11.8.3 Piramal Pharma Solutions Sterile Formulation Development Introduction

11.8.4 Piramal Pharma Solutions Revenue in Sterile Formulation Development Business (2021–2026)

11.8.5 Piramal Pharma Solutions Recent Development

11.9 Ardena

11.9.1 Ardena Company Details

11.9.2 Ardena Business Overview

11.9.3 Ardena Sterile Formulation Development Introduction

11.9.4 Ardena Revenue in Sterile Formulation Development Business (2021–2026)

11.9.5 Ardena Recent Development

11.10 Curida

11.10.1 Curida Company Details

11.10.2 Curida Business Overview

11.10.3 Curida Sterile Formulation Development Introduction

11.10.4 Curida Revenue in Sterile Formulation Development Business (2021–2026)

11.10.5 Curida Recent Development

11.11 Curia Global

11.11.1 Curia Global Company Details

11.11.2 Curia Global Business Overview

11.11.3 Curia Global Sterile Formulation Development Introduction

11.11.4 Curia Global Revenue in Sterile Formulation Development Business (2021–2026)

11.11.5 Curia Global Recent Development

11.12 Carbogen Amcis

11.12.1 Carbogen Amcis Company Details

11.12.2 Carbogen Amcis Business Overview

11.12.3 Carbogen Amcis Sterile Formulation Development Introduction

11.12.4 Carbogen Amcis Revenue in Sterile Formulation Development Business (2021–2026)

11.12.5 Carbogen Amcis Recent Development

11.13 Oakwood Labs

11.13.1 Oakwood Labs Company Details

11.13.2 Oakwood Labs Business Overview

11.13.3 Oakwood Labs Sterile Formulation Development Introduction

11.13.4 Oakwood Labs Revenue in Sterile Formulation Development Business (2021–2026)

11.13.5 Oakwood Labs Recent Development

11.14 Cambrex

11.14.1 Cambrex Company Details

11.14.2 Cambrex Business Overview

11.14.3 Cambrex Sterile Formulation Development Introduction

11.14.4 Cambrex Revenue in Sterile Formulation Development Business (2021–2026)

11.14.5 Cambrex Recent Development

11.15 Almac Group

11.15.1 Almac Group Company Details

11.15.2 Almac Group Business Overview

11.15.3 Almac Group Sterile Formulation Development Introduction

11.15.4 Almac Group Revenue in Sterile Formulation Development Business (2021–2026)

11.15.5 Almac Group Recent Development

11.16 Asymchem Group

11.16.1 Asymchem Group Company Details

11.16.2 Asymchem Group Business Overview

11.16.3 Asymchem Group Sterile Formulation Development Introduction

11.16.4 Asymchem Group Revenue in Sterile Formulation Development Business (2021–2026)

11.16.5 Asymchem Group Recent Development

11.17 AGC Biologics

11.17.1 AGC Biologics Company Details

11.17.2 AGC Biologics Business Overview

11.17.3 AGC Biologics Sterile Formulation Development Introduction

11.17.4 AGC Biologics Revenue in Sterile Formulation Development Business (2021–2026)

11.17.5 AGC Biologics Recent Development

11.18 WuXi AppTec

11.18.1 WuXi AppTec Company Details

11.18.2 WuXi AppTec Business Overview

11.18.3 WuXi AppTec Sterile Formulation Development Introduction

11.18.4 WuXi AppTec Revenue in Sterile Formulation Development Business (2021–2026)

11.18.5 WuXi AppTec Recent Development

11.19 Althea

11.19.1 Althea Company Details

11.19.2 Althea Business Overview

11.19.3 Althea Sterile Formulation Development Introduction

11.19.4 Althea Revenue in Sterile Formulation Development Business (2021–2026)

11.19.5 Althea Recent Development

11.20 Baxter

11.20.1 Baxter Company Details

11.20.2 Baxter Business Overview

11.20.3 Baxter Sterile Formulation Development Introduction

11.20.4 Baxter Revenue in Sterile Formulation Development Business (2021–2026)

11.20.5 Baxter Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Pfizer CentreOne

Piramal Pharma Solutions

Ardena

Curida

Curia Global

Carbogen-Amcis

Cambrex

Aenova Group

Catalent

Althea

Baxter

List of Tables

Table 1. Global Sterile Formulation Development Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Liquid Dosage Form

Table 3. Key Players of Lyophilized Dosage Form

Table 4. Key Players of Frozen Dosage Form

Table 5. Key Players of Others

Table 6. Global Sterile Formulation Development Market Size Growth Rate by Dosage Form (US$ Million): 2021 vs 2025 vs 2032

Table 7. Key Players of Injection

Table 8. Key Players of Ophthalmic

Table 9. Key Players of Inhalation

Table 10. Key Players of Others

Table 11. Global Sterile Formulation Development Market Size Growth Rate by Drug (US$ Million): 2021 vs 2025 vs 2032

Table 12. Key Players of Chemical Drugs

Table 13. Key Players of Biopharmaceuticals

Table 14. Key Players of Traditional Chinese Medicine

Table 15. Key Players of Others

Table 16. Global Sterile Formulation Development Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Sterile Formulation Development Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 18. Global Sterile Formulation Development Market Size by Region (US$ Million), 2021–2026

Table 19. Global Sterile Formulation Development Market Share by Region (2021–2026)

Table 20. Global Sterile Formulation Development Forecasted Market Size by Region (US$ Million), 2027–2032

Table 21. Global Sterile Formulation Development Market Share by Region (2027–2032)

Table 22. Sterile Formulation Development Market Trends

Table 23. Sterile Formulation Development Market Drivers

Table 24. Sterile Formulation Development Market Challenges

Table 25. Sterile Formulation Development Market Restraints

Table 26. Global Sterile Formulation Development Revenue by Players (US$ Million), 2021–2026

Table 27. Global Sterile Formulation Development Market Share by Players (2021–2026)

Table 28. Global Top Sterile Formulation Development Players by Tier (Tier 1, Tier 2, and Tier 3), based on Sterile Formulation Development Revenue, 2025

Table 29. Ranking of Global Top Sterile Formulation Development Companies by Revenue (US$ Million) in 2025

Table 30. Global 5 Largest Players Market Share by Sterile Formulation Development Revenue (CR5 and HHI), 2021–2026

Table 31. Global Key Players of Sterile Formulation Development, Headquarters and Area Served

Table 32. Global Key Players of Sterile Formulation Development, Products and Applications

Table 33. Global Key Players of Sterile Formulation Development, Date of General Availability (GA)

Table 34. Mergers and Acquisitions, Expansion Plans

Table 35. Global Sterile Formulation Development Market Size by Type (US$ Million), 2021–2026

Table 36. Global Sterile Formulation Development Revenue Market Share by Type (2021–2026)

Table 37. Global Sterile Formulation Development Forecasted Market Size by Type (US$ Million), 2027–2032

Table 38. Global Sterile Formulation Development Revenue Market Share by Type (2027–2032)

Table 39. Global Sterile Formulation Development Market Size by Application (US$ Million), 2021–2026

Table 40. Global Sterile Formulation Development Revenue Market Share by Application (2021–2026)

Table 41. Global Sterile Formulation Development Forecasted Market Size by Application (US$ Million), 2027–2032

Table 42. Global Sterile Formulation Development Revenue Market Share by Application (2027–2032)

Table 43. North America Sterile Formulation Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. North America Sterile Formulation Development Market Size by Country (US$ Million), 2021–2026

Table 45. North America Sterile Formulation Development Market Size by Country (US$ Million), 2027–2032

Table 46. Europe Sterile Formulation Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Europe Sterile Formulation Development Market Size by Country (US$ Million), 2021–2026

Table 48. Europe Sterile Formulation Development Market Size by Country (US$ Million), 2027–2032

Table 49. Asia-Pacific Sterile Formulation Development Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 50. Asia-Pacific Sterile Formulation Development Market Size by Region (US$ Million), 2021–2026

Table 51. Asia-Pacific Sterile Formulation Development Market Size by Region (US$ Million), 2027–2032

Table 52. Latin America Sterile Formulation Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 53. Latin America Sterile Formulation Development Market Size by Country (US$ Million), 2021–2026

Table 54. Latin America Sterile Formulation Development Market Size by Country (US$ Million), 2027–2032

Table 55. Middle East & Africa Sterile Formulation Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 56. Middle East & Africa Sterile Formulation Development Market Size by Country (US$ Million), 2021–2026

Table 57. Middle East & Africa Sterile Formulation Development Market Size by Country (US$ Million), 2027–2032

Table 58. Catalent Company Details

Table 59. Catalent Business Overview

Table 60. Catalent Sterile Formulation Development Product

Table 61. Catalent Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 62. Catalent Recent Development

Table 63. Lonza Group AG Company Details

Table 64. Lonza Group AG Business Overview

Table 65. Lonza Group AG Sterile Formulation Development Product

Table 66. Lonza Group AG Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 67. Lonza Group AG Recent Development

Table 68. Recipharm AB Company Details

Table 69. Recipharm AB Business Overview

Table 70. Recipharm AB Sterile Formulation Development Product

Table 71. Recipharm AB Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 72. Recipharm AB Recent Development

Table 73. Samsung Biologics Company Details

Table 74. Samsung Biologics Business Overview

Table 75. Samsung Biologics Sterile Formulation Development Product

Table 76. Samsung Biologics Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 77. Samsung Biologics Recent Development

Table 78. Aenova Group Company Details

Table 79. Aenova Group Business Overview

Table 80. Aenova Group Sterile Formulation Development Product

Table 81. Aenova Group Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 82. Aenova Group Recent Development

Table 83. Thermo Fisher Scientific Company Details

Table 84. Thermo Fisher Scientific Business Overview

Table 85. Thermo Fisher Scientific Sterile Formulation Development Product

Table 86. Thermo Fisher Scientific Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 87. Thermo Fisher Scientific Recent Development

Table 88. Pfizer CentreOne Company Details

Table 89. Pfizer CentreOne Business Overview

Table 90. Pfizer CentreOne Sterile Formulation Development Product

Table 91. Pfizer CentreOne Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 92. Pfizer CentreOne Recent Development

Table 93. Piramal Pharma Solutions Company Details

Table 94. Piramal Pharma Solutions Business Overview

Table 95. Piramal Pharma Solutions Sterile Formulation Development Product

Table 96. Piramal Pharma Solutions Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 97. Piramal Pharma Solutions Recent Development

Table 98. Ardena Company Details

Table 99. Ardena Business Overview

Table 100. Ardena Sterile Formulation Development Product

Table 101. Ardena Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 102. Ardena Recent Development

Table 103. Curida Company Details

Table 104. Curida Business Overview

Table 105. Curida Sterile Formulation Development Product

Table 106. Curida Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 107. Curida Recent Development

Table 108. Curia Global Company Details

Table 109. Curia Global Business Overview

Table 110. Curia Global Sterile Formulation Development Product

Table 111. Curia Global Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 112. Curia Global Recent Development

Table 113. Carbogen Amcis Company Details

Table 114. Carbogen Amcis Business Overview

Table 115. Carbogen Amcis Sterile Formulation Development Product

Table 116. Carbogen Amcis Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 117. Carbogen Amcis Recent Development

Table 118. Oakwood Labs Company Details

Table 119. Oakwood Labs Business Overview

Table 120. Oakwood Labs Sterile Formulation Development Product

Table 121. Oakwood Labs Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 122. Oakwood Labs Recent Development

Table 123. Cambrex Company Details

Table 124. Cambrex Business Overview

Table 125. Cambrex Sterile Formulation Development Product

Table 126. Cambrex Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 127. Cambrex Recent Development

Table 128. Almac Group Company Details

Table 129. Almac Group Business Overview

Table 130. Almac Group Sterile Formulation Development Product

Table 131. Almac Group Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 132. Almac Group Recent Development

Table 133. Asymchem Group Company Details

Table 134. Asymchem Group Business Overview

Table 135. Asymchem Group Sterile Formulation Development Product

Table 136. Asymchem Group Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 137. Asymchem Group Recent Development

Table 138. AGC Biologics Company Details

Table 139. AGC Biologics Business Overview

Table 140. AGC Biologics Sterile Formulation Development Product

Table 141. AGC Biologics Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 142. AGC Biologics Recent Development

Table 143. WuXi AppTec Company Details

Table 144. WuXi AppTec Business Overview

Table 145. WuXi AppTec Sterile Formulation Development Product

Table 146. WuXi AppTec Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 147. WuXi AppTec Recent Development

Table 148. Althea Company Details

Table 149. Althea Business Overview

Table 150. Althea Sterile Formulation Development Product

Table 151. Althea Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 152. Althea Recent Development

Table 153. Baxter Company Details

Table 154. Baxter Business Overview

Table 155. Baxter Sterile Formulation Development Product

Table 156. Baxter Revenue in Sterile Formulation Development Business (US$ Million), 2021–2026

Table 157. Baxter Recent Development

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Sterile Formulation Development Picture

Figure 2. Global Sterile Formulation Development Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Sterile Formulation Development Market Share by Type: 2025 vs 2032

Figure 4. Liquid Dosage Form Features

Figure 5. Lyophilized Dosage Form Features

Figure 6. Frozen Dosage Form Features

Figure 7. Others Features

Figure 8. Global Sterile Formulation Development Market Size Comparison by Dosage Form (US$ Million), 2021–2032

Figure 9. Injection Features

Figure 10. Ophthalmic Features

Figure 11. Inhalation Features

Figure 12. Others Features

Figure 13. Global Sterile Formulation Development Market Size Comparison by Drug (US$ Million), 2021–2032

Figure 14. Chemical Drugs Features

Figure 15. Biopharmaceuticals Features

Figure 16. Traditional Chinese Medicine Features

Figure 17. Others Features

Figure 18. Global Sterile Formulation Development Market Size by Application (US$ Million), 2021–2032

Figure 19. Global Sterile Formulation Development Market Share by Application: 2025 vs 2032

Figure 20. Preclinical Case Studies

Figure 21. Clinical Case Studies

Figure 22. Commercial Case Studies

Figure 23. Sterile Formulation Development Report Years Considered

Figure 24. Global Sterile Formulation Development Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 25. Global Sterile Formulation Development Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 26. Global Sterile Formulation Development Market Share by Region: 2025 vs 2032

Figure 27. Global Sterile Formulation Development Market Share by Players in 2025

Figure 28. Global Sterile Formulation Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 29. The Top 10 and 5 Players Market Share by Sterile Formulation Development Revenue in 2025

Figure 30. North America Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. North America Sterile Formulation Development Market Share by Country (2021–2032)

Figure 32. United States Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Canada Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Europe Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Europe Sterile Formulation Development Market Share by Country (2021–2032)

Figure 36. Germany Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. France Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. U.K. Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Italy Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Russia Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Ireland Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Asia-Pacific Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Asia-Pacific Sterile Formulation Development Market Share by Region (2021–2032)

Figure 44. China Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Japan Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. South Korea Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Southeast Asia Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. India Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Australia & New Zealand Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Latin America Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Latin America Sterile Formulation Development Market Share by Country (2021–2032)

Figure 52. Mexico Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Brazil Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Middle East & Africa Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. Middle East & Africa Sterile Formulation Development Market Share by Country (2021–2032)

Figure 56. Israel Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Saudi Arabia Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. UAE Sterile Formulation Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 59. Catalent Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 60. Lonza Group AG Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 61. Recipharm AB Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 62. Samsung Biologics Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 63. Aenova Group Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 65. Pfizer CentreOne Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 66. Piramal Pharma Solutions Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 67. Ardena Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 68. Curida Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 69. Curia Global Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 70. Carbogen Amcis Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 71. Oakwood Labs Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 72. Cambrex Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 73. Almac Group Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 74. Asymchem Group Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 75. AGC Biologics Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 76. WuXi AppTec Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 77. Althea Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 78. Baxter Revenue Growth Rate in Sterile Formulation Development Business (2021–2026)

Figure 79. Bottom-up and Top-down Approaches for This Report

Figure 80. Data Triangulation

Figure 81. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sterile Injection Development Market Research Report 2025

Sterile Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sterile Dosage Form Market Research Report 2025

Sterile Sponge Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sterile Solution for Injection Market Insights Forecast to 2030

Global Sterile Vial Market Research Report 2025

Global Sterile Powder Injection Market Research Report 2024

Global Cosmetics Development and Formulation Market Research Report 2024

Global Sterile Gel Market Insights Forecast to 2030

Global Formulation Development Service Market Research Report 2025

Global Sterile Dressing Market Research Report 2025

Global Sterile Cover Market Research Report 2024

Global Sterile Container Market Research Report 2024

Sterile Medical Device Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sterile Surgical Procedure Tray Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sterile Syringes Market Research Report 2025

Global Sterile Container Systems Market Research Report 2024

Global Sustained and Controlled Release Formulations Market Research Report 2025

Global Sterile Tubes Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions